Icatibant in the Treatment of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema
Joint Authors
Patel, Jaimin
Diwakar, Lavanya
Smith, Fang Gao
Crooks, Neil H.
Source
Issue
Vol. 2014, Issue 2014 (31 Dec. 2014), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2014-09-23
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
We describe the case of a 75-year-old woman who presented with massive tongue and lip swelling secondary to angiotensin-converting enzyme inhibitor-induced angioedema.
An awake fibre-optic intubation was performed because of impending airway obstruction.
As there was no improvement in symptoms after 72 hours, the selective bradykinin B2 receptor antagonist icatibant (Firazyr) was administered and the patient’s trachea was successfully extubated 36 hours later.
To our knowledge this is the first documented case of icatibant being used for the treatment of angiotensin-converting enzyme inhibitor-induced angioedema in the United Kingdom and represents a novel therapeutic option in its management.
American Psychological Association (APA)
Crooks, Neil H.& Patel, Jaimin& Diwakar, Lavanya& Smith, Fang Gao. 2014. Icatibant in the Treatment of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema. Case Reports in Critical Care،Vol. 2014, no. 2014, pp.1-3.
https://search.emarefa.net/detail/BIM-1034682
Modern Language Association (MLA)
Crooks, Neil H.…[et al.]. Icatibant in the Treatment of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema. Case Reports in Critical Care No. 2014 (2014), pp.1-3.
https://search.emarefa.net/detail/BIM-1034682
American Medical Association (AMA)
Crooks, Neil H.& Patel, Jaimin& Diwakar, Lavanya& Smith, Fang Gao. Icatibant in the Treatment of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema. Case Reports in Critical Care. 2014. Vol. 2014, no. 2014, pp.1-3.
https://search.emarefa.net/detail/BIM-1034682
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1034682
